C16025
Completed
NINLARO Capsules Drug Use-Results Survey (All-Case Surveillance) "Relapsed/Refractory Multiple Myeloma"
Clinicaltrials.gov
#NCT03169361Japic
#JapicCTI-173592About this clinical trial
The purpose of this study is to evaluate the safety of NINLARO in participants with relapsed/refractory multiple myeloma in daily clinical practice.
JP
Observational clinical trial.
At a glance
What medical conditions were being studied?
Multiple Myeloma
What was the clinical trial testing?
Ixazomib
How many participants were enrolled?
774
When was the clinical trial conducted?
May 2017 - Mar 2022
Key requirements
Sex
All
Age
All
Healthy volunteers?
No
Inclusion Criteria:
- All patients who have been confirmed as administration of the drug.
Exclusion Criteria:
- None